• PDA TR 54-2

PDA TR 54-2

  • Technical Report No. 54-2 (TR 54-2) Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing
  • Report / Survey by Parenteral Drug Association, 06/01/2013
  • Category: PDA

$325.00 $163.00

The first Annex to Technical Report No. 54: Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations provides specific case studies on how to apply quality risk management (QRM) to pharmaceutical manufacturing, specifically packaging and labeling operations. This report is intended to align with ICH Q9 and is one in a series of similar documents that provide additional examples of how to apply risk management tools across the product supply chain. Technical Report No. 54-2 was drafted by an all-volunteer team of experts representing companies like Merck, Amgen and Genentech.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 67

PDA TR 67

Technical Report No. 67, (TR 67) Exclusion of Objectionable Microorganisms from Nonsterile Pharmaceu..

$163.00 $325.00

PDA TR 68

PDA TR 68

Technical Report No. 68, (TR 68) Risk-Based Approach for Prevention and Management of Drug Shortages..

$86.00 $171.00

PDA TR 54-4

PDA TR 54-4

Technical Report No. 54-4, (TR 54-4) Implementation of Quality Risk Management for Pharmaceutical an..

$163.00 $325.00

PDA TR 57-2

PDA TR 57-2

Technical Report No. 57-2, (TR 57-2) Analytical Method Development and Qualification for Biotechnolo..

$163.00 $325.00